{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:35:22Z","timestamp":1793936122629,"version":"4.8.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70114114"],"award-info":[{"award-number":["70114114"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["INST 35\/1597-1 FUGG"],"award-info":[{"award-number":["INST 35\/1597-1 FUGG"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"\"la Caixa\" Foundation","doi-asserted-by":"publisher","award":["CLLSYSTEMS LCF\/PR\/HR22\/52420015 (HR22-00172)"],"award-info":[{"award-number":["CLLSYSTEMS LCF\/PR\/HR22\/52420015 (HR22-00172)"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    T-cell exhaustion contributes to immunotherapy failure in chronic lymphocytic leukemia (CLL). Here, we analyze T cells from CLL patients\u2019 blood, bone marrow, and lymph nodes, as well as from a CLL mouse model, using single-cell RNA sequencing, mass cytometry, and tissue imaging. T cells in CLL lymph nodes show the most distinct profiles, with accumulation of regulatory T cells and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells in various exhaustion states, including precursor (T\n                    <jats:sub>PEX<\/jats:sub>\n                    ) and terminally exhausted (T\n                    <jats:sub>EX<\/jats:sub>\n                    ) cells. Integration of T-cell receptor sequencing data and use of the predicTCR classifier suggest an enrichment of CLL-reactive T cells in lymph nodes. Interactome studies reveal potential immunotherapy targets, notably galectin-9, a TIM3 ligand. Inhibiting galectin-9 in mice reduces disease progression and TIM3\n                    <jats:sup>+<\/jats:sup>\n                    T cells. Galectin-9 expression also correlates with worse survival in CLL and other cancers, suggesting its role in immune evasion and potential as a therapeutic target.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-61822-x","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T09:34:51Z","timestamp":1754559291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0543-6084","authenticated-orcid":false,"given":"L.","family":"Lla\u00f3-Cid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JKL","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Fernandez Botana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2312-2954","authenticated-orcid":false,"given":"Y.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wierz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L-M","family":"Pilger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Floerchinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2529-1030","authenticated-orcid":false,"given":"CL","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gonder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4901-5173","authenticated-orcid":false,"given":"M.","family":"Chazotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8245-9846","authenticated-orcid":false,"given":"K.","family":"Bestak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2266-8621","authenticated-orcid":false,"given":"C.","family":"Schifflers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8603-4313","authenticated-orcid":false,"given":"M.","family":"Iskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6973-3531","authenticated-orcid":false,"given":"T.","family":"Roider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5868-2890","authenticated-orcid":false,"given":"F.","family":"Czernilofsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9992-3109","authenticated-orcid":false,"given":"P-M","family":"Bruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7059-4030","authenticated-orcid":false,"given":"JP","family":"Mallm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3686-8034","authenticated-orcid":false,"given":"A.","family":"Cosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DE","family":"Campton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gerhard-Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7486-8484","authenticated-orcid":false,"given":"D.","family":"Colomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-9793","authenticated-orcid":false,"given":"E.","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9391-5722","authenticated-orcid":false,"given":"D.","family":"Schapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-2298","authenticated-orcid":false,"given":"EW","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-1832","authenticated-orcid":false,"given":"S.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0879-8067","authenticated-orcid":false,"given":"E.","family":"Moussay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9460-5876","authenticated-orcid":false,"given":"J.","family":"Paggetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8287-5967","authenticated-orcid":false,"given":"M.","family":"Zapatka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5155-663X","authenticated-orcid":false,"given":"M.","family":"Seiffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"61822_CR1","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1182\/blood-2017-02-765685","volume":"129","author":"W Ding","year":"2017","unstructured":"Ding, W. et al. Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL. Blood 129, 3419\u20133427 (2017).","journal-title":"Blood"},{"key":"61822_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1182\/blood-2017-07-740993","volume":"131","author":"ZY Xu-Monette","year":"2018","unstructured":"Xu-Monette, Z. Y., Zhou, J. & Young, K. H. PD-1 expression and clinical PD-1 blockade in B-cell lymphomas. Blood 131, 68\u201383 (2018).","journal-title":"Blood"},{"key":"61822_CR3","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1200\/JCO.20.01467","volume":"38","author":"KM Cappell","year":"2020","unstructured":"Cappell, K. M. et al. Long-term follow-up of anti-CD19 chimeric antigen receptor T-cell therapy. J. Clin. Oncol. 38, 3805\u20133815 (2020).","journal-title":"J. Clin. Oncol."},{"key":"61822_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","volume":"24","author":"JA Fraietta","year":"2018","unstructured":"Fraietta, J. A. et al. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat. Med. 24, 563\u2013571 (2018).","journal-title":"Nat. Med."},{"key":"61822_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1182\/blood.2018885863","volume":"134","author":"JAC van Bruggen","year":"2019","unstructured":"van Bruggen, J. A. C. et al. Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8(+) T cells and impede CAR T-cell efficacy. Blood 134, 44\u201358 (2019).","journal-title":"Blood"},{"key":"61822_CR6","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank, C. U. et al. Defining \u2018T cell exhaustion. Nat. Rev. Immunol. 19, 665\u2013674 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"61822_CR7","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1038\/s41375-020-0873-2","volume":"34","author":"PM Roessner","year":"2020","unstructured":"Roessner, P. M. & Seiffert, M. T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease?. Leukemia 34, 2012\u20132024 (2020).","journal-title":"Leukemia"},{"key":"61822_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","volume":"537","author":"SJ Im","year":"2016","unstructured":"Im, S. J. et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537, 417 (2016).","journal-title":"Nature"},{"key":"61822_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","volume":"45","author":"DT Utzschneider","year":"2016","unstructured":"Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections. Immunity 45, 415\u2013427 (2016).","journal-title":"Immunity"},{"key":"61822_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","volume":"571","author":"AC Scott","year":"2019","unstructured":"Scott, A. C. et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nature 571, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"61822_CR11","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1016\/j.immuni.2021.11.004","volume":"54","author":"BS Hanna","year":"2021","unstructured":"Hanna, B. S. et al. Interleukin-10 receptor signaling promotes the maintenance of a PD-1(int) TCF-1(+) CD8(+) T cell population that sustains anti-tumor immunity. Immunity 54, 2825\u20132841.e2810 (2021).","journal-title":"Immunity"},{"key":"61822_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","volume":"27","author":"NS Joshi","year":"2007","unstructured":"Joshi, N. S. et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281\u2013295 (2007).","journal-title":"Immunity"},{"key":"61822_CR13","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.4049\/jimmunol.1102335","volume":"187","author":"JJ Obar","year":"2011","unstructured":"Obar, J. J. et al. Pathogen-induced inflammatory environment controls effector and memory CD8+ T cell differentiation.  J. Immunol. 187, 4967\u20134978 (2011).","journal-title":"J. Immunol."},{"key":"61822_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"McLane, L. M., Abdel-Hakeem, M. S. & Wherry, E. J. CD8 T cell exhaustion during chronic viral infection and cancer. Annu. Rev. Immunol. 37, 457\u2013495 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"61822_CR15","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1038\/s41375-021-01136-1","volume":"35","author":"PM Roessner","year":"2021","unstructured":"Roessner, P. M. et al. EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4(+) T cells in chronic lymphocytic leukemia. Leukemia 35, 2311\u20132324 (2021).","journal-title":"Leukemia"},{"key":"61822_CR16","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.immuni.2021.11.015","volume":"54","author":"DY Oh","year":"2021","unstructured":"Oh, D. Y. & Fong, L. Cytotoxic CD4(+) T cells in cancer: expanding the immune effector toolbox. Immunity 54, 2701\u20132711 (2021).","journal-title":"Immunity"},{"key":"61822_CR17","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41590-019-0346-9","volume":"20","author":"DV Sawant","year":"2019","unstructured":"Sawant, D. V. et al. Adaptive plasticity of IL-10(+) and IL-35(+) T(reg) cells cooperatively promotes tumor T cell exhaustion. Nat. Immunol. 20, 724\u2013735 (2019).","journal-title":"Nat. Immunol."},{"key":"61822_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02286-2","volume":"22","author":"R Dries","year":"2021","unstructured":"Dries, R. et al. Giotto: a toolbox for integrative analysis and visualization of spatial expression data. Genome Biol. 22, 78 (2021).","journal-title":"Genome Biol."},{"key":"61822_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.exger.2003.08.013","volume":"39","author":"S Gupta","year":"2004","unstructured":"Gupta, S. et al. Characterization of na\u00efve, memory and effector CD8+ T cells: effect of age. Exp. Gerontol. 39, 545\u2013550 (2004).","journal-title":"Exp. Gerontol."},{"key":"61822_CR20","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s43018-024-00796-z","volume":"5","author":"G Efe","year":"2024","unstructured":"Efe, G., Rustgi, A. K. & Prives, C. p53 at the crossroads of tumor immunity. Nat. Cancer 5, 983\u2013995 (2024).","journal-title":"Nat. Cancer"},{"key":"61822_CR21","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"},{"key":"61822_CR22","doi-asserted-by":"publisher","first-page":"abe6474","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"61822_CR23","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","volume":"24","author":"X Guo","year":"2018","unstructured":"Guo, X. et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat. Med. 24, 978\u2013985 (2018).","journal-title":"Nat. Med."},{"key":"61822_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23324-4","volume":"12","author":"M Andreatta","year":"2021","unstructured":"Andreatta, M. et al. Interpretation of T cell states from single-cell transcriptomics data using reference atlases. Nat. Commun. 12, 2965 (2021).","journal-title":"Nat. Commun."},{"key":"61822_CR25","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/bioinformatics\/btv715","volume":"32","author":"P Angerer","year":"2016","unstructured":"Angerer, P. et al. destiny: diffusion maps for large-scale single-cell data in R. Bioinformatics 32, 1241\u20131243 (2016).","journal-title":"Bioinformatics"},{"key":"61822_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s43018-021-00292-8","volume":"3","author":"B Liu","year":"2022","unstructured":"Liu, B. et al. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nat. Cancer 3, 108\u2013121 (2022).","journal-title":"Nat. Cancer"},{"key":"61822_CR27","doi-asserted-by":"crossref","unstructured":"Tan, C. L. et al. Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy. Nat. Biotechnol. 43, 134\u2013142 (2024).","DOI":"10.1038\/s41587-024-02161-y"},{"key":"61822_CR28","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41587-020-0505-4","volume":"38","author":"H Huang","year":"2020","unstructured":"Huang, H., Wang, C., Rubelt, F., Scriba, T. J. & Davis, M. M. Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening. Nat. Biotechnol. 38, 1194\u20131202 (2020).","journal-title":"Nat. Biotechnol."},{"key":"61822_CR29","doi-asserted-by":"publisher","first-page":"e3000314","DOI":"10.1371\/journal.pbio.3000314","volume":"17","author":"MV Pogorelyy","year":"2019","unstructured":"Pogorelyy, M. V. et al. Detecting T cell receptors involved in immune responses from single repertoire snapshots. PLoS Biol. 17, e3000314 (2019).","journal-title":"PLoS Biol."},{"key":"61822_CR30","doi-asserted-by":"crossref","unstructured":"Huisman, W. et al. Public T-Cell Receptors (TCRs) revisited by analysis of the magnitude of identical and highly-similar TCRs in virus-specific T-cell repertoires of healthy individuals. Front. Immunol. 13, 851868 (2022).","DOI":"10.3389\/fimmu.2022.851868"},{"key":"61822_CR31","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nmeth.4077","volume":"13","author":"D T\u00fcrei","year":"2016","unstructured":"T\u00fcrei, D., Korcsm\u00e1ros, T. & Saez-Rodriguez, J. OmniPath: guidelines and gateway for literature-curated signaling pathway resources. Nat. Methods 13, 966\u2013967 (2016).","journal-title":"Nat. Methods"},{"key":"61822_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"61822_CR33","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1182\/blood-2012-05-431452","volume":"121","author":"N Reinart","year":"2013","unstructured":"Reinart, N. et al. Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor. Blood 121, 812\u2013821 (2013).","journal-title":"Blood"},{"key":"61822_CR34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","volume":"10","author":"T Aoki","year":"2020","unstructured":"Aoki, T. et al. Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma. Cancer Discov. 10, 406\u2013421 (2020).","journal-title":"Cancer Discov."},{"key":"61822_CR35","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1182\/blood-2008-07-170415","volume":"113","author":"JA Burger","year":"2009","unstructured":"Burger, J. A. et al. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation. Blood 113, 3050\u20133058 (2009).","journal-title":"Blood"},{"key":"61822_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00262-012-1300-y","volume":"62","author":"S Kiaii","year":"2013","unstructured":"Kiaii, S. et al. T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile. Cancer Immunol. Immunotherapy: CII 62, 51\u201363 (2013).","journal-title":"Cancer Immunol. Immunotherapy: CII"},{"key":"61822_CR37","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1182\/blood-2017-06-792267","volume":"131","author":"M Wierz","year":"2018","unstructured":"Wierz, M. et al. Dual PD1\/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia. Blood 131, 1617\u20131621 (2018).","journal-title":"Blood"},{"key":"61822_CR38","doi-asserted-by":"publisher","first-page":"6545921","DOI":"10.1155\/2020\/6545921","volume":"2020","author":"L Karabon","year":"2020","unstructured":"Karabon, L. et al. Abnormal expression of BTLA and CTLA-4 immune checkpoint molecules in chronic lymphocytic leukemia patients. J. Immunol. Res. 2020, 6545921 (2020).","journal-title":"J. Immunol. Res."},{"key":"61822_CR39","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio, S. et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257\u20131265 (2007).","journal-title":"J. Exp. Med."},{"key":"61822_CR40","doi-asserted-by":"publisher","first-page":"e21556","DOI":"10.1096\/fj.202100013R","volume":"35","author":"N Pang","year":"2021","unstructured":"Pang, N. et al. Activated Galectin-9\/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia.  FASEB J. 35, e21556 (2021).","journal-title":"FASEB J."},{"key":"61822_CR41","first-page":"1019","volume":"17","author":"K Wdowiak","year":"2019","unstructured":"Wdowiak, K. et al. Increased serum levels of Galectin\u20119 in patients with chronic lymphocytic leukemia. Oncol. Lett. 17, 1019\u20131029 (2019).","journal-title":"Oncol. Lett."},{"key":"61822_CR42","first-page":"1021","volume":"36","author":"A Xierenguli","year":"2020","unstructured":"Xierenguli, A. et al. TIM-3\/galectin-9 is involved in negative regulation of T cells in patients with chronic lymphocytic leukemia]. Xi Bao Yu Fen. Zi Mian Yi Xue Za Zhi 36, 1021\u20131025 (2020).","journal-title":"Xi Bao Yu Fen. Zi Mian Yi Xue Za Zhi"},{"key":"61822_CR43","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1017\/S1462399408000719","volume":"10","author":"RY Yang","year":"2008","unstructured":"Yang, R. Y., Rabinovich, G. A. & Liu, F. T. Galectins: structure, function and therapeutic potential. Expert Rev. Mol. Med 10, e17 (2008).","journal-title":"Expert Rev. Mol. Med"},{"key":"61822_CR44","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/ni1271","volume":"6","author":"C Zhu","year":"2005","unstructured":"Zhu, C. et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6, 1245\u20131252 (2005).","journal-title":"Nat. Immunol."},{"key":"61822_CR45","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1073\/pnas.102181599","volume":"99","author":"R Bichi","year":"2002","unstructured":"Bichi, R. et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc. Natl Acad. Sci. USA 99, 6955\u20136960 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"61822_CR46","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","volume":"181","author":"DY Oh","year":"2020","unstructured":"Oh, D. Y. et al. Intratumoral CD4(+) T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer. Cell 181, 1612\u20131625.e1613 (2020).","journal-title":"Cell"},{"key":"61822_CR47","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1084\/jem.20091921","volume":"207","author":"Y Xie","year":"2010","unstructured":"Xie, Y. et al. Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma. J. Exp. Med. 207, 651\u2013667 (2010).","journal-title":"J. Exp. Med."},{"key":"61822_CR48","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.20091918","volume":"207","author":"SA Quezada","year":"2010","unstructured":"Quezada, S. A. et al. Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J. Exp. Med. 207, 637\u2013650 (2010).","journal-title":"J. Exp. Med."},{"key":"61822_CR49","doi-asserted-by":"crossref","unstructured":"Li, C., Tang, Z., Zhang, W., Ye, Z. & Liu, F. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 49, W242\u2013W246 (2021).","DOI":"10.1093\/nar\/gkab418"},{"key":"61822_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33385-8","volume":"13","author":"SA Herbst","year":"2022","unstructured":"Herbst, S. A. et al. Proteogenomics refines the molecular classification of chronic lymphocytic leukemia. Nat. Commun. 13, 6226 (2022).","journal-title":"Nat. Commun."},{"key":"61822_CR51","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1158\/2159-8290.CD-19-0499","volume":"9","author":"L Vuong","year":"2019","unstructured":"Vuong, L., Kotecha, R. R., Voss, M. H. & Hakimi, A. A. Tumor microenvironment dynamics in clear-cell renal cell carcinoma. Cancer Discov. 9, 1349\u20131357 (2019).","journal-title":"Cancer Discov."},{"key":"61822_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1092-z","volume":"17","author":"Y \u015eenbabao\u011flu","year":"2016","unstructured":"\u015eenbabao\u011flu, Y. et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 17, 231 (2016).","journal-title":"Genome Biol."},{"key":"61822_CR53","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00262-020-02608-6","volume":"69","author":"R Jikuya","year":"2020","unstructured":"Jikuya, R. et al. Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma. Cancer Immunol. Immunother. 69, 2041\u20132051 (2020).","journal-title":"Cancer Immunol. Immunother."},{"key":"61822_CR54","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1016\/j.csbj.2021.08.019","volume":"19","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. The molecular feature of macrophages in tumor immune microenvironment of glioma patients. Comput. Struct. Biotechnol. J. 19, 4603\u20134618 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"61822_CR55","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1182\/blood-2018-06-845156","volume":"133","author":"MS Khodadoust","year":"2019","unstructured":"Khodadoust, M. S. et al. B-cell lymphomas present immunoglobulin neoantigens. Blood 133, 878\u2013881 (2019).","journal-title":"Blood"},{"key":"61822_CR56","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2014-04-567933","volume":"124","author":"M Rajasagi","year":"2014","unstructured":"Rajasagi, M. et al. Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia. Blood 124, 453\u2013462 (2014).","journal-title":"Blood"},{"key":"61822_CR57","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","volume":"185","author":"Q Huang","year":"2022","unstructured":"Huang, Q. et al. The primordial differentiation of tumor-specific memory CD8(+) T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes. Cell 185, 4049\u20134066.e4025 (2022).","journal-title":"Cell"},{"key":"61822_CR58","doi-asserted-by":"publisher","first-page":"eabg7836","DOI":"10.1126\/sciimmunol.abg7836","volume":"6","author":"KA Connolly","year":"2021","unstructured":"Connolly, K. A. et al. A reservoir of stem-like CD8(+) T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response. Sci. Immunol. 6, eabg7836 (2021).","journal-title":"Sci. Immunol."},{"key":"61822_CR59","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.ccell.2023.08.013","volume":"41","author":"EM Parry","year":"2023","unstructured":"Parry, E. M. et al. ZNF683 marks a CD8(+) T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome. Cancer cell 41, 1803\u20131816.e1808 (2023).","journal-title":"Cancer cell"},{"key":"61822_CR60","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1084\/jem.177.1.213","volume":"177","author":"M Buschle","year":"1993","unstructured":"Buschle, M. et al. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J. Exp. Med. 177, 213\u2013218 (1993).","journal-title":"J. Exp. Med."},{"key":"61822_CR61","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","volume":"20","author":"Y Wolf","year":"2020","unstructured":"Wolf, Y., Anderson, A. C. & Kuchroo, V. K. TIM3 comes of age as an inhibitory receptor. Nat. Rev. Immunol. 20, 173\u2013185 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"61822_CR62","doi-asserted-by":"publisher","first-page":"e21556","DOI":"10.1096\/fj.202100013R","volume":"35","author":"N Pang","year":"2021","unstructured":"Pang, N. et al. Activated Galectin-9\/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia. FASEB J. 35, e21556 (2021).","journal-title":"FASEB J."},{"key":"61822_CR63","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1158\/1078-0432.CCR-20-4746","volume":"27","author":"G Curigliano","year":"2021","unstructured":"Curigliano, G. et al. Phase I\/Ib clinical trial of sabatolimab, an anti-TIM-3 antibody, alone and in combination with spartalizumab, an anti-PD-1 antibody, in advanced solid tumors. Clin. Cancer Res. 27, 3620\u20133629 (2021).","journal-title":"Clin. Cancer Res."},{"key":"61822_CR64","first-page":"A267","volume":"8","author":"C Sabatos-Peyton","year":"2020","unstructured":"Sabatos-Peyton, C. et al. 439 Dual modes of action for anti-TIM-3 antibody MBG453 in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML): preclinical evidence for immune-mediated and anti-leukemic activity. J. Immunother. Cancer 8, A267 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"61822_CR65","doi-asserted-by":"publisher","first-page":"e1385690","DOI":"10.1080\/2162402X.2017.1385690","volume":"7","author":"CA Sabatos-Peyton","year":"2018","unstructured":"Sabatos-Peyton, C. A. et al. Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy. Oncoimmunology 7, e1385690 (2018).","journal-title":"Oncoimmunology"},{"key":"61822_CR66","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ccell.2017.11.019","volume":"33","author":"\u00c1 de Mingo Pulido","year":"2018","unstructured":"de Mingo Pulido, \u00c1 et al. TIM-3 regulates CD103+ dendritic cell function and response to chemotherapy in breast cancer. Cancer cell 33, 60\u201374.e66 (2018).","journal-title":"Cancer cell"},{"key":"61822_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01041-7","volume":"14","author":"C Doba\u00f1o-L\u00f3pez","year":"2024","unstructured":"Doba\u00f1o-L\u00f3pez, C. et al. Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target. Blood Cancer J. 14, 75 (2024).","journal-title":"Blood Cancer J."},{"key":"61822_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21099-2","volume":"12","author":"R Yang","year":"2021","unstructured":"Yang, R. et al. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nat. Commun. 12, 832 (2021).","journal-title":"Nat. Commun."},{"key":"61822_CR69","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nm.4314","volume":"23","author":"D Daley","year":"2017","unstructured":"Daley, D. et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat. Med. 23, 556\u2013567 (2017).","journal-title":"Nat. Med."},{"key":"61822_CR70","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molimm.2017.11.014","volume":"110","author":"BS Hanna","year":"2019","unstructured":"Hanna, B. S., \u00d6zt\u00fcrk, S. & Seiffert, M. Beyond bystanders: myeloid cells in chronic lymphocytic leukemia. Mol. Immunol. 110, 77\u201387 (2019).","journal-title":"Mol. Immunol."},{"key":"61822_CR71","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G. & Stevenson, F. K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94, 1848\u20131854 (1999).","journal-title":"Blood"},{"key":"61822_CR72","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle, R. N. et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94, 1840\u20131847 (1999).","journal-title":"Blood"},{"key":"61822_CR73","doi-asserted-by":"publisher","first-page":"11713","DOI":"10.1073\/pnas.0604564103","volume":"103","author":"XJ Yan","year":"2006","unstructured":"Yan, X. J. et al. B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 103, 11713\u201311718 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"61822_CR74","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/leu.2015.305","volume":"30","author":"BS Hanna","year":"2016","unstructured":"Hanna, B. S. et al. Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo. Leukemia 30, 570\u2013579 (2016).","journal-title":"Leukemia"},{"key":"61822_CR75","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1182\/blood-2013-12-546416","volume":"124","author":"R Jitschin","year":"2014","unstructured":"Jitschin, R. et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood 124, 750\u2013760 (2014).","journal-title":"Blood"},{"key":"61822_CR76","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1182\/blood-2015-01-622936","volume":"126","author":"F McClanahan","year":"2015","unstructured":"McClanahan, F. et al. PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia. Blood 126, 203\u2013211 (2015).","journal-title":"Blood"},{"key":"61822_CR77","doi-asserted-by":"crossref","unstructured":"Lin, J. R. et al. Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes. Elife 7, e31657 (2018).","DOI":"10.7554\/eLife.31657"},{"key":"61822_CR78","doi-asserted-by":"publisher","unstructured":"Lin, J.-R. et al. Multi-modal digital pathology for colorectal cancer diagnosis by high-plex immunofluorescence imaging and traditional histology of the same tissue section. bioRxiv https:\/\/doi.org\/10.1101\/2022.09.28.509927 (2022).","DOI":"10.1101\/2022.09.28.509927"},{"key":"61822_CR79","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41592-021-01308-y","volume":"19","author":"D Schapiro","year":"2022","unstructured":"Schapiro, D. et al. MCMICRO: a scalable, modular image-processing pipeline for multiplexed tissue imaging. Nat. Methods 19, 311\u2013315 (2022).","journal-title":"Nat. Methods"},{"key":"61822_CR80","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s42003-022-04076-3","volume":"5","author":"C Yapp","year":"2022","unstructured":"Yapp, C. et al. UnMICST: Deep learning with real augmentation for robust segmentation of highly multiplexed images of human tissues. Commun. Biol. 5, 1263 (2022).","journal-title":"Commun. Biol."},{"key":"61822_CR81","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41587-019-0207-y","volume":"37","author":"SK Saka","year":"2019","unstructured":"Saka, S. K. et al. Immuno-SABER enables highly multiplexed and amplified protein imaging in tissues. Nat. Biotechnol. 37, 1080\u20131090 (2019).","journal-title":"Nat. Biotechnol."},{"key":"61822_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"61822_CR83","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1017\/S1431927622006328","volume":"28","author":"C-L Chiu","year":"2022","unstructured":"Chiu, C.-L. & Clack, N. & community, t. n. napari: a Python multi-dimensional image viewer platform for the research community. Microsc. Microanalysis 28, 1576\u20131577 (2022).","journal-title":"Microsc. Microanalysis"},{"key":"61822_CR84","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/bioinformatics\/btab877","volume":"38","author":"CR Harris","year":"2022","unstructured":"Harris, C. R. et al. Quantifying and correcting slide-to-slide variation in multiplexed immunofluorescence images. Bioinformatics 38, 1700\u20131707 (2022).","journal-title":"Bioinformatics"},{"key":"61822_CR85","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","volume":"162","author":"JH Levine","year":"2015","unstructured":"Levine, J. H. et al. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis. Cell 162, 184\u2013197 (2015).","journal-title":"Cell"},{"key":"61822_CR86","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.immuni.2018.04.026","volume":"48","author":"B Bengsch","year":"2018","unstructured":"Bengsch, B. et al. Epigenomic-guided mass cytometry profiling reveals disease-specific features of exhausted CD8 T cells. Immunity 48, 1029\u20131045.e1025 (2018).","journal-title":"Immunity"},{"key":"61822_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-10-106","volume":"10","author":"F Hahne","year":"2009","unstructured":"Hahne, F. et al. flowCore: a Bioconductor package for high throughput flow cytometry. BMC Bioinform. 10, 106 (2009).","journal-title":"BMC Bioinform."},{"key":"61822_CR88","doi-asserted-by":"publisher","first-page":"E2770","DOI":"10.1073\/pnas.1408792111","volume":"111","author":"RV Bruggner","year":"2014","unstructured":"Bruggner, R. V., Bodenmiller, B., Dill, D. L., Tibshirani, R. J. & Nolan, G. P. Automated identification of stratifying signatures in cellular subpopulations. Proc. Natl Acad. Sci. USA 111, E2770\u2013E2777 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"61822_CR89","doi-asserted-by":"publisher","first-page":"15430","DOI":"10.1021\/jacs.8b09440","volume":"140","author":"DM Chevrier","year":"2018","unstructured":"Chevrier, D. M. et al. Molecular-scale ligand effects in small gold-thiolate nanoclusters. J. Am. Chem. Soc. 140, 15430\u201315436 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"61822_CR90","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen, S. et al. FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data. Cytom. A 87, 636\u2013645 (2015).","journal-title":"Cytom. A"},{"key":"61822_CR91","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"61822_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GX Zheng","year":"2017","unstructured":"Zheng, G. X. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).","journal-title":"Nat. Commun."},{"key":"61822_CR93","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329\u2013337.e324 (2019).","journal-title":"Cell Syst."},{"key":"61822_CR94","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"61822_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14766-3","volume":"11","author":"K Van den Berge","year":"2020","unstructured":"Van den Berge, K. et al. Trajectory-based differential expression analysis for single-cell sequencing data. Nat. Commun. 11, 1201 (2020).","journal-title":"Nat. Commun."},{"key":"61822_CR96","doi-asserted-by":"publisher","first-page":"47","DOI":"10.12688\/f1000research.22139.1","volume":"9","author":"N Borcherding","year":"2020","unstructured":"Borcherding, N., Bormann, N. L. & Kraus, G. scRepertoire: an R-based toolkit for single-cell immune receptor analysis. F1000Res 9, 47 (2020).","journal-title":"F1000Res"},{"key":"61822_CR97","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/bioinformatics\/btz474","volume":"36","author":"R Orenbuch","year":"2020","unstructured":"Orenbuch, R. et al. arcasHLA: high-resolution HLA typing from RNAseq. Bioinformatics 36, 33\u201340 (2020).","journal-title":"Bioinformatics"},{"key":"61822_CR98","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nmeth.3364","volume":"12","author":"DA Bolotin","year":"2015","unstructured":"Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380\u2013381 (2015).","journal-title":"Nat. Methods"},{"key":"61822_CR99","doi-asserted-by":"publisher","first-page":"D419","DOI":"10.1093\/nar\/gkx760","volume":"46","author":"M Shugay","year":"2018","unstructured":"Shugay, M. et al. VDJdb: a curated database of T-cell receptor sequences with known antigen specificity. Nucleic Acids Res. 46, D419\u2013D427 (2018).","journal-title":"Nucleic Acids Res."},{"key":"61822_CR100","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/bioinformatics\/btv557","volume":"32","author":"M Franz","year":"2016","unstructured":"Franz, M. et al. Cytoscape.js: a graph theory library for visualisation and analysis. Bioinformatics 32, 309\u2013311 (2016).","journal-title":"Bioinformatics"},{"key":"61822_CR101","doi-asserted-by":"publisher","first-page":"e9923","DOI":"10.15252\/msb.20209923","volume":"17","author":"D T\u00fcrei","year":"2021","unstructured":"T\u00fcrei, D. et al. Integrated intra- and intercellular signaling knowledge for multicellular omics analysis. Mol. Syst. Biol. 17, e9923 (2021).","journal-title":"Mol. Syst. Biol."},{"key":"61822_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30755-0","volume":"13","author":"D Dimitrov","year":"2022","unstructured":"Dimitrov, D. et al. Comparison of methods and resources for cell-cell communication inference from single-cell RNA-Seq data. Nat. Commun. 13, 3224 (2022).","journal-title":"Nat. Commun."},{"key":"61822_CR103","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., Chen, T. & Zhang, Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 47, W556\u2013w560 (2019).","journal-title":"Nucleic Acids Res."},{"key":"61822_CR104","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ccell.2021.02.015","volume":"39","author":"K Bi","year":"2021","unstructured":"Bi, K. et al. Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma. Cancer Cell 39, 649\u2013661.e645 (2021).","journal-title":"Cancer Cell"},{"key":"61822_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28372-y","volume":"13","author":"N Abdelfattah","year":"2022","unstructured":"Abdelfattah, N. et al. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat. Commun. 13, 767 (2022).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61822-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61822-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61822-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:35:56Z","timestamp":1757345756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61822-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61822"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-61822-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"29 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.S. reports funding from GSK and received fees\/honoraria from Immunai, Noetik, Alpenglow and Lunaphore. K.B. reports fees from Lunaphore. C.L.T. and E.W.G. hold patents and PCT applications describing methods to identify tumor-reactive T cells, and are founders or employees of Tcelltech GmbH. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7271"}}